Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2021
Developing a digital assistive tool for dementia patients and their caregivers: A qualitative study on needs, potential functions, practical requirements, user acceptance, and ethical considerationsLenka J Wichmann, Nele Reiff, Sophie Zintl, et al.Behavioural Pharmacology|July 18, 2002
Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preferenceJ Kotlińska, J Wichmann, A Legowska, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Structure-activity relationships of substituted 5H-thiazolo[3,2-a]pyrimidines as group 2 metabotropic glutamate receptor antagonistsJ Wichmann, G Adam, S Kolczewski, et al.Der Unfallchirurg|July 13, 2021
[Oncologic aspects in treatment of pathologic fractures]H Eggers, J Wichmann, M Omar, et al.Dental Materials : Official Publication of the Academy of Dental Materials|May 1, 1992
Quantitation of total mercury vapor released during dental proceduresJ H Engle, J L Ferracane, J Wichmann, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1979
The dependence of coronary collateral blood flow on regional vascular resistances. Pharmacological studies with glyceryl trinitrate, adenosine and verapamilG Ertl, F Simm, J Wichmann, et al.Nuclear Medicine and Biology|November 17, 2001
Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agentM Ogawa, K Hatano, Y Kawasumi, et al.Acta Endocrinologica|July 1, 1982
Immunological and clinical characterization of patients with untreated euthyroid and hypothyroid autoimmune thyroiditis. Antibody spectrum, response to TRH and clinical studyW A Scherbaum, G Stöckle, J Wichmann, et al.Basic Research in Cardiology|September 1, 1982
Influence of the ischemic coronary bed on collateral blood flowG Ertl, M Fuchs, S Oswald, et al.Bioorganic & Medicinal Chemistry Letters|April 27, 2000
ORL1 receptor ligands: structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-onesS Röver, J Wichmann, F Jenck, et al.Pageof 6